RVLPQ — RVL Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for RVL Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	70.8	95.9	114	43.5	44.5
Net Total Accounts Receivable
Net Total Receivables	56.4	43.9	26.4	2.13	3.03
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	172	173	173	59.4	57
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	31.3	35.2	30.8	2.23	1.79
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	796	463	371	145	129
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	114	75.9	55.8	20.1	19.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	412	349	277	67.9	77.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	384	115	93.9	76.7	51.1
Total Liabilities & Shareholders' Equity	796	463	371	145	129
Total Common Shares Outstanding